Quince Therapeutics, Inc. (QNCX) Stock Analysis
DELISTED
What happened to Quince Therapeutics, Inc. (QNCX) stock?
Quince Therapeutics, Inc. (QNCX) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
Market cap $8.83M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quince Therapeutics, Inc. (QNCX). Quince Therapeutics, Inc. is a biopharmaceutical company focused on advancing precision therapeutics for rare diseases. Their lead compound, NOV004, targets bone fractures using a bone-targeting drug platform.
Last analyzed: May 10, 2026Quince Therapeutics, Inc. (QNCX) Healthcare & Pipeline Overview
More about this archive record
Can I still buy QNCX shares?
No. QNCX stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for QNCX elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before QNCX stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Quince Therapeutics, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.